XML 21 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Investments in Other Entities
6 Months Ended
Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Investments in Other Entities
5.
Investments in Other Entities

Equity Method

For the six months ended June 30, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):

 

% of
Ownership

 

December 31,
2023

 

 

Initial
Investment

 

 

Allocation
of Net
Income (Loss)

 

 

Distribution

 

 

June 30, 2024

 

LaSalle Medical Associates – IPA line of business

 

25%

 

$

9,866

 

 

$

 

 

$

1,161

 

 

$

 

 

$

11,027

 

Pacific Medical Imaging & Oncology Center, Inc.

 

40%

 

 

1,691

 

 

 

 

 

 

(43

)

 

 

 

 

 

1,648

 

CAIPA MSO, LLC

 

30%

 

 

13,660

 

 

 

 

 

 

440

 

 

 

 

 

 

14,100

 

I Health, Inc.

 

25%

 

 

 

 

 

5,968

 

 

 

(45

)

 

 

 

 

 

5,923

 

Other *

 

25%

 

 

557

 

 

 

 

 

 

21

 

 

 

 

 

 

578

 

 

 

 

$

25,774

 

 

$

5,968

 

 

$

1,534

 

 

$

 

 

$

33,276

 

 

 

% of
Ownership

 

December 31,
2022

 

 

Initial
Investment

 

 

Allocation
of Net
Income (Loss)

 

 

Distribution

 

 

June 30, 2023

 

LaSalle Medical Associates – IPA line of business

 

25%

 

$

5,684

 

 

$

 

 

$

4,853

 

 

$

 

 

$

10,537

 

Pacific Medical Imaging & Oncology Center, Inc.

 

40%

 

 

1,878

 

 

 

 

 

 

(223

)

 

 

 

 

 

1,655

 

531 W. College, LLC **

 

50%

 

 

17,281

 

 

 

 

 

 

(211

)

 

 

 

 

 

17,070

 

One MSO, LLC **

 

50%

 

 

2,718

 

 

 

 

 

 

242

 

 

 

 

 

 

2,960

 

CAIPA MSO, LLC

 

30%

 

 

12,738

 

 

 

 

 

 

451

 

 

 

 

 

 

13,189

 

Other *

 

25%

 

 

 

 

 

325

 

 

 

95

 

 

 

 

 

 

420

 

 

 

 

$

40,299

 

 

$

325

 

 

$

5,207

 

 

$

 

 

$

45,831

 

* Other consists of smaller equity method investments.

** Investments were solely for the benefit of APC and its shareholders.

For three months ended June 30, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):

 

% of
Ownership

 

March 31,
2024

 

 

Initial
Investment

 

 

Allocation
of Net
Income (Loss)

 

 

Distribution

 

 

June 30, 2024

 

LaSalle Medical Associates – IPA line of business

 

25%

 

$

10,225

 

 

$

 

 

$

802

 

 

$

 

 

$

11,027

 

Pacific Medical Imaging & Oncology Center, Inc.

 

40%

 

 

1,718

 

 

 

 

 

 

(70

)

 

 

 

 

 

1,648

 

CAIPA MSO, LLC

 

30%

 

 

13,846

 

 

 

 

 

 

254

 

 

 

 

 

 

14,100

 

I Health, Inc.

 

25%

 

 

9,487

 

 

 

(3,519

)

 

 

(45

)

 

 

 

 

 

5,923

 

Other *

 

25%

 

 

617

 

 

 

 

 

 

(39

)

 

 

 

 

 

578

 

 

 

 

$

35,893

 

 

$

(3,519

)

 

$

902

 

 

$

 

 

$

33,276

 

 

 

% of
Ownership

 

March 31,
2023

 

 

Initial
Investment

 

 

Allocation
of Net
Income (Loss)

 

 

Distribution

 

 

June 30, 2023

 

LaSalle Medical Associates – IPA line of business

 

25%

 

$

7,848

 

 

$

 

 

$

2,689

 

 

$

 

 

$

10,537

 

Pacific Medical Imaging & Oncology Center, Inc.

 

40%

 

 

1,886

 

 

 

 

 

 

(231

)

 

 

 

 

 

1,655

 

531 W. College, LLC **

 

50%

 

 

17,191

 

 

 

 

 

 

(121

)

 

 

 

 

 

17,070

 

One MSO, LLC **

 

50%

 

 

2,833

 

 

 

 

 

 

127

 

 

 

 

 

 

2,960

 

CAIPA MSO, LLC

 

30%

 

 

12,988

 

 

 

 

 

 

201

 

 

 

 

 

 

13,189

 

Other *

 

25%

 

 

362

 

 

 

 

 

 

58

 

 

 

 

 

 

420

 

 

 

 

$

43,108

 

 

$

 

 

$

2,723

 

 

$

 

 

$

45,831

 

 

I Health, Inc.

On March 31, 2024, a wholly owned subsidiary of the Company acquired a 25% equity interest in I Health, Inc. (“I Health”), a management service organization. The Company accounts for its investment in I Health under the equity method of accounting as the Company has the ability to exercise significant influence, but not control over I Health’s operations. The purchase agreement includes a call option that allows the Company to purchase an additional 25% equity interest on each of the first, second and third anniversary of the purchase (“I Health Call Option”). The total purchase price for this arrangement was $9.9 million, consisting of $3.9 million in the form of a call option, and $6.0 million as the initial investment of the 25% equity interest. The I Health Call Option is presented within other assets in the accompanying condensed consolidated balance sheet.

There was no impairment loss recorded related to equity method investments for the three and six months ended June 30, 2024 and 2023.